Histogen logo 300.jpg
Histogen Reports First Quarter 2021 Earnings and Provides Business Update
13 mai 2021 16h01 HE | Histogen Inc
Strengthened Balance Sheet with $20.8 Million of Gross Proceeds from Financing and Warrant Exercises Initiated Phase 1 Study of Emricasan in Symptomatic COVID-19 Patients with Top-Line Data...
Surrozen Logo FINAL Large-1.png
Surrozen Strengthens Board of Directors with Appointments of Mace Rothenberg, M.D., and Christopher Chai
06 mai 2021 08h00 HE | Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today...
Bone Bank Allografts Announces Partnership Capstone Health Alliance
27 avr. 2021 16h30 HE | Bone Bank Allografts (BBA)
SAN ANTONIO, April 27, 2021 (GLOBE NEWSWIRE) -- Bone Bank Allografts (BBA), a leading provider of regenerative medicine technologies to the surgical community, announced a multi-year supplier...
AMR Logo.png
South Korea Cell Culture Market to Garner $606.4 Million by 2027: Allied Market Research
27 avr. 2021 10h20 HE | Allied Market Research
Portland, OR , April 27, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the South Korea cell culture market was accounted for $216.3 million in 2019, and is...
lsif-logo-default (1).png
Sernova to Webcast Live at Life Sciences Investor Forum March 25th
22 mars 2021 10h36 HE | Life Sciences Investor Forum
LONDON, Ontario, March 22, 2021 (GLOBE NEWSWIRE) -- Sernova Corp. (OTCQB:SEOVF)(TSX-V:SVA)(FSE/XETRA:PSH), a leading clinical-stage company focused on developing regenerative medicine therapeutics...
Histogen logo 300.jpg
Histogen Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
16 févr. 2021 08h00 HE | Histogen Inc
HST-001 Found to be Safe and Well Tolerated with No Serious Adverse Events Planning Underway for Next Clinical Study in U.S. SAN DIEGO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ:...
Emergen logo.png
Regenerative Medicine Market to be Valued at USD 6.49 Billion by 2027 | The Escalating Burden of Chronic Diseases and Genetic Aberrations will be the Major Factor Driving the Industry Growth, says Emergen Research
04 févr. 2021 07h46 HE | Emergen Research
Vancouver, British Columbia, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The Global Regenerative Medicine Market is predicted to attain a market valuation of USD 6.49 billion by 2027, growing at a CAGR of...
Reports and Data.jpeg-01
Regenerative Medicine Market Size Worth $23.57 Bn By 2027; High demand for 3D bioprinting of tissues and organs to better understand their mechanism is driving revenue growth of this segment currently | Reports and Data
18 janv. 2021 08h51 HE | Reports and Data
New York, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Increased investment in advanced technologies for treatment of genetic and chronic diseases is driving growth of the regenerative medicine market. Market...
Histogen logo 300.jpg
Histogen to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
06 janv. 2021 08h00 HE | Histogen Inc
SAN DIEGO, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite...
Histogen logo 300.jpg
Histogen Announces Closing of $14.0 Million Upsized Public Offering
05 janv. 2021 16h05 HE | Histogen Inc
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (Nasdaq: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class therapeutics that ignite the body’s...